My ePortfolio Register   

SIOG 2016 /
AML: Is less as good as more?

17th - 19th Nov 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.11.16
Views: 287

Dr Rebecca Olin - University of California San Francisco, San Francisco,, USA

Dr Olin speaks with ecancertv at SIOG 2016 about treatment of elderly patients with AML.

She discusses the survival outcomes for patients who are eligible for reduced intensity alginate transplants, alongside redefining geriatric assessments to improve treatment.

This service has been kindly supported by an unrestricted grant from Merck/MSD.

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence